Expression and selective inhibition of the constitutive and inducible forms of human cyclo-oxygenase

Biochem J. 1995 Jan 15;305 ( Pt 2)(Pt 2):479-84. doi: 10.1042/bj3050479.

Abstract

The enzyme cyclo-oxygenase catalyses the oxygenation of arachidonic acid, leading to the formation of prostaglandins. Recently two forms of cyclo-oxygenase have been described: a constitutive (COX-1) enzyme present in most cells and tissues, and an inducible (COX-2) isoenzyme observed in many cells in response to pro-inflammatory cytokines. Constitutive and inducible forms of human cyclo-oxygenase (hCOX-1 and hCOX-2) were cloned and expressed in insect cells, utilizing a baculovirus expression system. hCOX-1 had a specific activity of 18.8 mumol of O2/mg with a Km of 13.8 microM for arachidonate and Vmax. of 1500 nmol of O2/nmol of enzyme, whereas hCOX-2 had a specific activity of 12.2 mumol of O2/mg with a Km of 8.7 microM for arachidonate and a Vmax. of 1090 nmol of O2/nmol of enzyme. Indomethacin inhibited both hCOX-1 and hCOX-2, whereas NS-398 and Dup-697 selectively inhibited hCOX-2. Both NS-398 and Dup-697 exhibited time-dependent inactivation of hCOX-2, as did indomethacin on both enzymes. The competitive inhibitor of hCOX-1, mefenamic acid, also displayed competitive inhibition of hCOX-2. These results demonstrate the ability to generate selective non-steroidal anti-inflammatory drugs (NSAIDs), which could provide useful improvement therapeutically in the treatment of chronic inflammatory disease.

Publication types

  • Comparative Study

MeSH terms

  • Animals
  • Arachidonic Acid / metabolism
  • Baculoviridae / genetics
  • Cloning, Molecular
  • Cyclooxygenase Inhibitors / pharmacology*
  • DNA, Complementary / genetics
  • Dose-Response Relationship, Drug
  • Enzyme Activation
  • Gene Expression Regulation, Enzymologic*
  • Humans
  • Indomethacin / pharmacology
  • Nitrobenzenes / pharmacology
  • Oxygen Consumption
  • Prostaglandin-Endoperoxide Synthases / biosynthesis
  • Prostaglandin-Endoperoxide Synthases / drug effects*
  • Prostaglandin-Endoperoxide Synthases / isolation & purification
  • Prostaglandin-Endoperoxide Synthases / metabolism
  • Recombinant Proteins / biosynthesis
  • Recombinant Proteins / metabolism
  • Spodoptera / cytology
  • Sulfonamides / pharmacology
  • Thiophenes / pharmacology
  • Time Factors

Substances

  • Cyclooxygenase Inhibitors
  • DNA, Complementary
  • Nitrobenzenes
  • Recombinant Proteins
  • Sulfonamides
  • Thiophenes
  • N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide
  • Arachidonic Acid
  • DuP 697
  • Prostaglandin-Endoperoxide Synthases
  • Indomethacin